Wednesday, August 5, 2026

Yoon Suk Yeol’s Calls Alleged Shadow Line Controversy Absurd

On May 8, it was reported that...

North Korea Drone Breach: What You Need to Know About the Ongoing Investigation

A military-police task force is investigating a North Korean drone incursion, targeting military and intelligence personnel for treason.

Privacy Invasion: Young Man Faces Jail for Covertly Recording Women

A man in his twenties who secretly...

Health

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.

Revolutionizing Stroke Treatment: JLK’s AI Solution in 22 Hospitals

JLK, a medical AI firm, initiates a large-scale clinical study on stroke AI imaging solutions across 22 hospitals in Korea.

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.
Latest

KIMES 2026: How South Korea’s Medical Device Industry is Poised for Global Expansion

KIMES 2026 showcases Korea's medical device sector, highlighting digital growth and global expansion opportunities for domestic companies.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

How This New Blood Test Using Nanotechnology Could Change Brain Disease Monitoring Forever

South Korean researchers developed a blood test to track brain disease progression, potentially replacing imaging scans for monitoring.

How the New MOU Between Financial and Medical Institutions Will Transform Care for the Underprivileged

A new support system links community finance with public healthcare to aid financially vulnerable populations in accessing medical assistance.

Unlocking the Future of Healthcare: How Dong-A ST and Dou are Revolutionizing AI Solutions in 2026

Dong-A ST partners with Dou for AI solutions to enhance digital healthcare and improve patient experiences in hospitals nationwide.

SleepQ vs. Traditional Medications: Which is the Future of Insomnia Treatment?

Welt aims to complete clinical trials for its SleepQ insomnia device by year-end, targeting listing on Germany's DiGA reimbursement system.

Lotte Biologics at DCAT Week 2026: Unveiling Strategic Collaborations in Global CDMO

Lotte Biologics will attend DCAT Week in New York to pursue global CDMO partnerships and showcase its production capabilities.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

South Korea’s Pharmaceutical Future: 500 Million USD Investment from Eli Lilly to Boost K-Bio Innovation

South Korea partners with Eli Lilly to boost biotech and pharma industries, investing $500M to enhance innovation and healthcare access.

Curiosis: Revolutionizing Bio Research with Automated Cell Imaging Systems

Curiosis enhances biomedical research with automated cell analysis, aiming for profitability and becoming a leading lab automation provider.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.